SPOT-it™ Screening Kits

Kits detecting TREC, KREC and SMN1 for newborn screening of SCID, XLA and SMA by rtPCR.

More detailed product information

SPOT-it™ Screening Kits are screening products for severe combined immunodeficiency (SCID), agammaglobulinemia (XLA) and spinal muscular atrophy (SMA) in newborns.

SCID and XLA screening is performed by semi-quantitative detection of TREC and KREC, while qualitative detection of exon 7 of the SMN1 gene is used for SMA screening.

The tests are based on the analysis of DNA isolated from dried blood drops followed by rtPCR and are designed for a high number of samples without the need to use expensive machines.

The products are compatible with the QuantStudio 5/QuantStudio 5 Dx instrument and are CE-IVD certified.

1-2015-T, 12-2015-T	SPOT-it™ TREC Screening Kit	SCID	82, 984
1-2015-TK, 12-2015-TK	SPOT-it™ TREC & KREC Screening Kit	SCID, XLA	81, 972
1-2020-TS, 12-2020-TS	SPOT-it™ TREC & SMN1 Screening Kit	SCID, SMA	82, 984
1-2020-TKS, 12-2020-TKS	SPOT-it™ TREC, KREC & SMN1 Screening Kit	SCID, XLA, SMA	81, 972

For more information, please contact us by e-mail: diagnostika@pentagen.cz